Weber Capital Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.6M Sell
1,356,602
-16,547
-1% -$188K 15.02% 4
2026
Q1
$15.6M Sell
1,373,149
-27,000
-2% -$293K 15.6% 3
2025
Q4
$18M Buy
+1,400,149
New +$17.3M 16.98% 2

Other funds holding ANGO

Weber Capital Management's ANGO Position: Q2 2026 in Review

Weber Capital Management reduced its AngioDynamics (ANGO) stake by 1.2% in Q2 2026, selling an estimated $188K and leaving 1,356,602 shares worth $17.6M. The position accounts for 15.02% of the portfolio, ranked #4.

Weber Capital Management first reported a position in ANGO in Q4 2025 and has held it in 3 quarters since. The position peaked at $18M in Q4 2025. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Weber Capital Management held 1,356,602 shares of AngioDynamics worth $17.6M as of Q2 2026.
  • Weber Capital Management sold 16,547 AngioDynamics shares in Q2 2026, an estimated $188K.
  • AngioDynamics made up 15.02% of Weber Capital Management's portfolio in Q2 2026, its #4 holding.
  • Weber Capital Management first reported a position in AngioDynamics in Q4 2025 and has held it in 3 quarters since.
  • Weber Capital Management's AngioDynamics position peaked at $18M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Weber Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.